UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.425

Sortiert nach

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

BMC cancer, 2018-02, Vol.18 (1), p.130-130, Article 130

2018

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy

Journal of the American Academy of Dermatology, 2015-05, Vol.72 (5), p.780-785.e3

2015

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Journal of hematology and oncology, 2017-08, Vol.10 (1), p.152-152, Article 152

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification

Journal of the American Academy of Dermatology, 2017-05, Vol.76 (5), p.818-825.e3

2017

Link zum Volltext

Verfügbarkeit prüfen

The Structure of the Follistatin:Activin Complex Reveals Antagonism of Both Type I and Type II Receptor Binding

Developmental cell, 2005-10, Vol.9 (4), p.535-543

2005

Link zum Volltext

Verfügbarkeit prüfen

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Diagnostic pathology, 2018-02, Vol.13 (1), p.13-13, Article 13

2018

Link zum Volltext

Verfügbarkeit prüfen

Postnatal regulation of germ cells by activin: The establishment of the initial follicle pool

Developmental biology, 2006-10, Vol.298 (1), p.132-148

2006

Link zum Volltext

Verfügbarkeit prüfen

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients

Diagnostic pathology, 2022-02, Vol.17 (1), p.32-32, Article 32

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study

Journal of Oncology, 2016-01, Vol.2016, p.5325762-9

2016

Link zum Volltext

Verfügbarkeit prüfen

Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics

Diagnostic pathology, 2017-08, Vol.12 (1), p.59-59, Article 59

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria

Journal of the American Academy of Dermatology, 2019-01, Vol.80 (1), p.149-157.e4

2019

Link zum Volltext

Verfügbarkeit prüfen

A gene signature to determine metastatic behavior in thymomas

PloS one, 2013-07, Vol.8 (7), p.e66047-e66047

2013

Link zum Volltext

Verfügbarkeit prüfen

Variability of High-risk Uveal Melanoma Survival Estimates Across Studies Based on 15-Gene Expression Profiling

JAMA ophthalmology, 2023-02, Vol.141 (2), p.212

2023

Link zum Volltext

Verfügbarkeit prüfen

Comments on Post-Publication Discussion of “Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma”

Annals of surgical oncology, 2022-08, Vol.29 (8), p.5239-5240

2022

Link zum Volltext

Verfügbarkeit prüfen

Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers

Journal of surgical oncology, 2019-02, Vol.119 (2), p.175-186

2019

Link zum Volltext

Verfügbarkeit prüfen

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

Clinical cancer research, 2015-01, Vol.21 (1), p.175-183

2015

Link zum Volltext

Verfügbarkeit prüfen

Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients

Journal of the American Academy of Dermatology, 2020-09, Vol.83 (3), p.745-753

2020

Link zum Volltext

Verfügbarkeit prüfen

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

Journal of the American Academy of Dermatology, 2022-12, Vol.87 (6), p.1312-1320

2022

Link zum Volltext

Verfügbarkeit prüfen

Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma

Journal of the American Academy of Dermatology, 2021-02, Vol.84 (2), p.361-369

2021

Link zum Volltext

Verfügbarkeit prüfen

Response to: “Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?”

Journal of the American Academy of Dermatology, 2019-06, Vol.80 (6), p.e163-e164

2019

Link zum Volltext

Verfügbarkeit prüfen

Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Journal of hematology and oncology, 2017-10, Vol.10 (1), p.160-160, Article 160

2017

Link zum Volltext

Verfügbarkeit prüfen

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

Current medical research and opinion, 2022-08, Vol.38 (8), p.1267-1274

2022

Link zum Volltext

Verfügbarkeit prüfen

Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients

Current medical research and opinion, 2016-09, Vol.32 (9), p.1599-1604

2016

Link zum Volltext

Verfügbarkeit prüfen

Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management

Current medical research and opinion, 2020-08, Vol.36 (8), p.1301-1307

2020

Link zum Volltext

Verfügbarkeit prüfen

Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review

Head & neck, 2021-09, Vol.43 (9), p.2822-2843

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.425

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.258)
Mit Volltextzugriff
(1.218)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

2 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(875)
Life Sciences & Biomedicine
(692)
Humans
(531)
Male
(339)
Female
(320)
Biological And Medical Sciences
(264)
Animals
(207)
Medical Sciences
(186)
Middle Aged
(169)
Adult
(166)
Aged
(142)
Physical Sciences
(128)
General & Internal Medicine
(89)
Technology
(88)
Fundamental And Applied Biological Sciences. Psychology
(86)
Adolescent
(76)
Risk Factors
(75)
Medicine, General & Internal
(68)
Mice
(63)
Treatment Outcome
(63)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)
... seit 90 Tagen
(10)

Menü

Weitere Dienste

Einstellungen

Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients

Gene expression profiling for molecular staging of cutaneous melanoma in patients undergoing sentinel lymph node biopsy

Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Identification of high-risk cutaneous melanoma tumors is improved when combining the online American Joint Committee on Cancer Individualized Melanoma Patient Outcome Prediction Tool with a 31-gene expression profile–based classification

The Structure of the Follistatin:Activin Complex Reveals Antagonism of Both Type I and Type II Receptor Binding

Analytic validity of DecisionDx-Melanoma, a gene expression profile test for determining metastatic risk in melanoma patients

Postnatal regulation of germ cells by activin: The establishment of the initial follicle pool

Analytical validity of DecisionDx-SCC, a gene expression profile test to identify risk of metastasis in cutaneous squamous cell carcinoma (SCC) patients

Clinical Performance and Management Outcomes with the DecisionDx-UM Gene Expression Profile Test in a Prospective Multicenter Study

Gene expression profiling in uveal melanoma: technical reliability and correlation of molecular class with pathologic characteristics

Identification of patients at risk of metastasis using a prognostic 31-gene expression profile in subpopulations of melanoma patients with favorable outcomes by standard criteria

A gene signature to determine metastatic behavior in thymomas

Variability of High-risk Uveal Melanoma Survival Estimates Across Studies Based on 15-Gene Expression Profiling

Comments on Post-Publication Discussion of “Evaluation of a Gene Expression Profiling Assay in Primary Cutaneous Melanoma”

Identification of risk in cutaneous melanoma patients: Prognostic and predictive markers

Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma

Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients

Optimizing treatment approaches for patients with cutaneous melanoma by integrating clinical and pathologic features with the 31-gene expression profile test

Validation of a 40-gene expression profile test to predict metastatic risk in localized high-risk cutaneous squamous cell carcinoma

Response to: “Use of a prognostic gene expression profile test for T1 cutaneous melanoma: Will it help or harm patients?”

Erratum to: Interim analysis of survival in a prospective, multi-center registry cohort of cutaneous melanoma tested with a prognostic 31-gene expression profile test

Expanded evidence that the 31-gene expression profile test provides clinical utility for melanoma management in a multicenter study

Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients

Integrating gene expression profiling into NCCN high-risk cutaneous squamous cell carcinoma management recommendations: impact on patient management

Adjuvant therapy for high‐risk cutaneous squamous cell carcinoma: 10‐year review

Suchergebnisse filtern